CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- 4 Grant or award General Counsel acquired 154 shares (grant or award)
- 4 Open-market sale Director sold 1,000 shares at $183.54 ($183,540)
- 4 Open-market sale Chief Commercial Officer sold 23,540 shares at $215.00 ($5,061,100)
- 4 Grant or award Director acquired 814 shares (grant or award)
- 4 Grant or award Director acquired 814 shares (grant or award)
- 4 Grant or award Director acquired 814 shares (grant or award)
- 4 Returned to the company Director returned 1,270 shares (to the company)
- 4 Grant or award Director acquired 814 shares (grant or award)
- 4 Grant or award Director acquired 814 shares (grant or award)
- 4 Open-market sale Director sold 1,000 shares at $204.55 ($204,550)
- 4 Open-market sale Chief Medical Officer sold 1,833 shares at $200.00 ($366,600)
- 4 Open-market sale Chief Medical Officer sold 1,943 shares at $180.48 ($350,673)
- 4 Open-market sale Chief Medical Officer sold 4,095 shares at an average $184.38 ($755,055)
- 4 Open-market sale Chief Science Officer sold 5,650 shares at $189.65 ($1,071,523)
- 4 Open-market sale Chief Commercial Officer sold 1,290 shares at $199.67 ($257,574)
- 4 Open-market sale Director sold 1,000 shares at $199.67 ($199,670)
- 4 Open-market sale Chief Commercial Officer sold 1,043 shares at $200.86 ($209,493)
- 4 Open-market sale Executive Chairman sold 95,000 shares at an average $199.55 ($18,957,452)
- 4 Open-market sale Chief Executive Officer sold 97,973 shares at $196.34 ($19,236,323)
- 4 Open-market sale Director sold 6,000 shares at an average $198.84 ($1,193,035)
Page 15 of 39 · 780 filings